{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:19:01Z","timestamp":1787314741081,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T00:00:00Z","timestamp":1676073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Science and Technology Project of Guangzhou Health Commission","award":["20221A011091"],"award-info":[{"award-number":["20221A011091"]}]},{"name":"Guangzhou science and technology project","award":["202102010084"],"award-info":[{"award-number":["202102010084"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-023-06946-5","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T04:05:36Z","timestamp":1676088336000},"page":"871-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical analysis of 78 patients with nonclassical 21-hydroxylase deficiency"],"prefix":"10.1007","volume":"308","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0317-8990","authenticated-orcid":false,"given":"En","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengcong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailv","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-8694","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,11]]},"reference":[{"key":"6946_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jsbmb.2016.06.015","volume":"165","author":"AA Parsa","year":"2016","unstructured":"Parsa AA (2016) New MI. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 165:2\u201311. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.06.015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"6946_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","volume":"349","author":"PW Speiser","year":"2003","unstructured":"Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349(8):776\u2013788. https:\/\/doi.org\/10.1056\/NEJMra021561","journal-title":"N Engl J Med"},{"key":"6946_CR3","doi-asserted-by":"publisher","first-page":"105554","DOI":"10.1016\/j.jsbmb.2019.105554","volume":"198","author":"V Guarnotta","year":"2020","unstructured":"Guarnotta V, Niceta M, Bono M, Marchese S et al (2020) Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 198:105554. https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105554","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"6946_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-015-0656-0","volume":"50","author":"H Falhammar","year":"2015","unstructured":"Falhammar H, Nordenstr\u00f6m A (2015) Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine 50(1):1\u201319. https:\/\/doi.org\/10.1007\/s12020-015-0656-0","journal-title":"Endocrine"},{"issue":"2","key":"6946_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ecl.2015.02.002","volume":"44","author":"AF Turcu","year":"2015","unstructured":"Turcu AF, Auchus RJ (2015) Adrenal steroidogenesis and congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 44(2):275\u2013296. https:\/\/doi.org\/10.1016\/j.ecl.2015.02.002","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"6946_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmx014","volume":"23","author":"E Carmina","year":"2017","unstructured":"Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Azziz R (2017) Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update 23(5):1\u201320. https:\/\/doi.org\/10.1093\/humupd\/dmx014","journal-title":"Hum Reprod Update"},{"issue":"4","key":"6946_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/cen.12543","volume":"82","author":"D Livadas","year":"2015","unstructured":"Livadas D, Dastamani S et al (2015) The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene. Clin Endocrinol 82(4):543\u2013549. https:\/\/doi.org\/10.1111\/cen.12543","journal-title":"Clin Endocrinol"},{"issue":"5","key":"6946_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s00404-022-06700-3","volume":"306","author":"R Li","year":"2022","unstructured":"Li R, Mai T, Zheng S, Zhang Y (2022) Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT. Arch Gynecol Obstet 306(5):1711\u20131721. https:\/\/doi.org\/10.1007\/s00404-022-06700-3","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"6946_CR9","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/humrep\/det105","volume":"28","author":"MC Amato","year":"2013","unstructured":"Amato MC, Guarnotta V, Forti D, Donatelli M et al (2013) Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. Hum Reprod 28(7):1919\u20131928. https:\/\/doi.org\/10.1093\/humrep\/det105","journal-title":"Hum Reprod"},{"issue":"10","key":"6946_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fendo.2019.00388","volume":"19","author":"G Papadakis","year":"2019","unstructured":"Papadakis G, Kandaraki EA, Tseniklidi E, Papalou O et al (2019) Polycystic ovary syndrome and NC-CAH: distinct Characteristics and common findings. A Systematic Review. Front Endocrinol 19(10):388. https:\/\/doi.org\/10.3389\/fendo.2019.00388","journal-title":"Front Endocrinol"},{"issue":"3","key":"6946_CR11","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/EJE-18-0712","volume":"180","author":"A Nordenstrom","year":"2019","unstructured":"Nordenstrom A, Falhammar H (2019) MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency. Eur J Endocrinol 180(3):R127\u2013R145. https:\/\/doi.org\/10.1530\/EJE-18-0712","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"6946_CR12","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"Speiser PW, Wiebke A, Auchus RJ, Baskin LS et al (2018) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103(11):4043\u20134088. https:\/\/doi.org\/10.1210\/jc.2018-01865","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6946_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1210\/jc.2008-1582","volume":"94","author":"B Maud","year":"2009","unstructured":"Maud B, Christine B-C, Marie-B\u00e9atrice G-P, V\u00e9ronique T et al (2009) Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 94(5):1570\u20131578. https:\/\/doi.org\/10.1210\/jc.2008-1582","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6946_CR14","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1067\/mob.2000.108020","volume":"183","author":"C Moran","year":"2000","unstructured":"Moran C, Azziz R, Carmina E, Dewailly D et al (2000) 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 183(6):1468\u20131474. https:\/\/doi.org\/10.1067\/mob.2000.108020","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"6946_CR15","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/cen.13429","volume":"87","author":"O Eyal","year":"2017","unstructured":"Eyal O, Ayalon-Dangur I, Segev-Becker A, Schachter-Davidov A, Weintrob N (2017) Pregnancy in women with nonclassic congenital adrenal hyperplasia: time to conceive and outcome. Clin Endocrinol (Oxf) 87(5):552\u2013556. https:\/\/doi.org\/10.1111\/cen.13429","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"16","key":"6946_CR16","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.26355\/eurrev_202108_26537","volume":"25","author":"H Cengiz","year":"2021","unstructured":"Cengiz H, Demirci T, Varim C, Cetin S (2021) Establishing a new screening 17 hydroxyprogesterone cut-off value and evaluation of the reliability of the long intramuscular ACTH stimulation test in the diagnosis of nonclassical congenital adrenal hyperplasia. Eur Rev Med Pharmacol Sci 25(16):5235\u20135240. https:\/\/doi.org\/10.26355\/eurrev_202108_26537","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"6946_CR17","first-page":"215","volume":"39","author":"S Sahmay","year":"2014","unstructured":"Sahmay S, Tuten A, Gurleyen H, Oncul M, Erel CT (2014) Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation. Minerva Endocrinol 39(3):215\u201322","journal-title":"Minerva Endocrinol"},{"issue":"2","key":"6946_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1210\/jc.2007-2053","volume":"93","author":"HF Escobar-Morreale","year":"2008","unstructured":"Escobar-Morreale HF, Sanch\u00f3n R, San Mill\u00e1n JL (2008) A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 93(2):527\u2013533. https:\/\/doi.org\/10.1210\/jc.2007-2053","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt A","key":"6946_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsbmb.2016.03.035","volume":"165","author":"V Kusec","year":"2017","unstructured":"Kusec V, Dumic M et al (2017) Molecular genetic analysis in 93 patients and 193 family membeis with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia. J Steroid Biochem Mol Biol 165(Pt A):51\u201356. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.035","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"6946_CR20","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1210\/jc.2006-0062","volume":"91","author":"C Moran","year":"2006","unstructured":"Moran C, Azziz R, Weintrob N, Witchel SF et al (2006) Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 91(9):3451\u20133456. https:\/\/doi.org\/10.1210\/jc.2006-0062","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6946_CR21","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1210\/jc.2009-1383","volume":"95","author":"M Bidet","year":"2010","unstructured":"Bidet M, Bellann\u00e9-Chantelot C, Galand-Portier MB, Golmard JL et al (2010) Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 95(3):1182\u20131190. https:\/\/doi.org\/10.1210\/jc.2009-1383","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"6946_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1373\/clinchem.2010.146035","volume":"56","author":"A Dauber","year":"2010","unstructured":"Dauber A, Kellogg M, Majzoub JA (2010) Monitoring of Therapy in Congenital Adrenal Hyperplasia. Clin Chem 56(8):1245\u20131251. https:\/\/doi.org\/10.1373\/clinchem.2010.146035","journal-title":"Clin Chem"},{"issue":"9","key":"6946_CR23","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser PW, Azziz R, Baskin LS, Ghizzoni L et al (2010) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 95(9):4133\u20134160. https:\/\/doi.org\/10.1210\/jc.2009-2631","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6946_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2003-43307","volume":"21","author":"C Moran","year":"2003","unstructured":"Moran C, Azziz R (2003) 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Semin Reprod Med 21(3):295\u2013300. https:\/\/doi.org\/10.1055\/s-2003-43307","journal-title":"Semin Reprod Med"},{"issue":"2","key":"6946_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00404-022-06505-4","volume":"306","author":"N Hanedan","year":"2022","unstructured":"Hanedan N, Ersoy B, Hanedan C, Ozyurt BC, Taneli F (2022) Effect of the presence of polycystic ovary syndrome-related features on anti-Mullerian hormone and androstenedione levels in adolescents with or without menstrual irregularity. Arch Gynecol Obstet 306(2):523\u2013531. https:\/\/doi.org\/10.1007\/s00404-022-06505-4","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"6946_CR26","first-page":"650","volume":"37","author":"PW Speiser","year":"1985","unstructured":"Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37(4):650\u2013667 (PMID: 9556656)","journal-title":"Am J Hum Genet"},{"issue":"4","key":"6946_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ymgme.2006.12.005","volume":"90","author":"RC Wilson","year":"2007","unstructured":"Wilson RC, Nimkarn S, Dumic M, Obeid J, Azar MR, Najmabadi H, Saffari F, New MI (2007) Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 90(4):414\u2013421. https:\/\/doi.org\/10.1016\/j.ymgme.2006.12.005","journal-title":"Mol Genet Metab"},{"issue":"3","key":"6946_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/MED.0b013e3283534db2","volume":"19","author":"SF Witchel","year":"2012","unstructured":"Witchel SF (2012) Nonclassic congenital adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes 19(3):151\u2013158. https:\/\/doi.org\/10.1097\/MED.0b013e3283534db2","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"6946_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/OGX.0b013e318193301b","volume":"64","author":"E Trakakis","year":"2009","unstructured":"Trakakis E, Loghis C, Kassanos D (2009) Congenital adrenal hyperplasia because of 21-hydroxylase deficiency. a genetic disorder of interest to obstetricians and gynecologists. Obstet Gynecol Surv 64(3):177\u2013189. https:\/\/doi.org\/10.1097\/OGX.0b013e318193301b","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"6946_CR30","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/EJE-18-0712","volume":"180","author":"A Nordenstr\u00f6m","year":"2019","unstructured":"Nordenstr\u00f6m A, Falhammar H (2019) Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency. Eur J Endocrinol 180(3):R127\u2013R145. https:\/\/doi.org\/10.1530\/EJE-18-0712","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"6946_CR31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/s0002-9378(99)70498-9","volume":"181","author":"C Moran","year":"1999","unstructured":"Moran C, Potter HD, Reyna R, Boots LR, Azziz R (1999) Prevalence of 3beta-hydroxysteroid dehydrogenase-deficient nonclassic adrenal hyperplasia in hyperandrogenic women with adrenal androgen excess. Am J Obstet Gynecol 181(3):596\u2013600. https:\/\/doi.org\/10.1016\/s0002-9378(99)70498-9","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"6946_CR32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","volume":"94","author":"M Pall","year":"2009","unstructured":"Pall M, Azziz R, Beires J, Pignatelli D (2009) The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 94(2):684\u2013689. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.06.025","journal-title":"Fertil Steril"},{"issue":"2","key":"6946_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.gene.2013.03.082","volume":"526","author":"FB Coeli-Lacchini","year":"2013","unstructured":"Coeli-Lacchini FB, Turatti W, Elias PC, Elias LL et al (2013) A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Gene 526(2):239\u201345. https:\/\/doi.org\/10.1016\/j.gene.2013.03.082","journal-title":"Gene"},{"issue":"1","key":"6946_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.15537\/smj.2015.1.9697","volume":"36","author":"S Mohamed","year":"2015","unstructured":"Mohamed S, El-Kholy S, Al-Juryyan N, Al-Nemri AM, Abu-Amero KK (2015) A CYP21A2 gene mutation in patients with congenital adrenal hyperplasia Molecular genetics report from Saudi Arabia. Saudi Med J 36(1):113\u20136. https:\/\/doi.org\/10.15537\/smj.2015.1.9697","journal-title":"Saudi Med J"},{"key":"6946_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000321223","volume":"20","author":"A Wedell","year":"2011","unstructured":"Wedell A (2011) Molecular genetics of 21-hydroxylase deficiency. Endocr Dev 20:80\u201387. https:\/\/doi.org\/10.1159\/000321223","journal-title":"Endocr Dev"},{"issue":"2","key":"6946_CR36","doi-asserted-by":"publisher","first-page":"E346","DOI":"10.1210\/jc.2012-3343","volume":"98","author":"N Krone","year":"2013","unstructured":"Krone N, Rose IT, Willis DS, Hodson J et al (2013) Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort. J Clin Endocrinol Metab 98(2):E346\u2013E354. https:\/\/doi.org\/10.1210\/jc.2012-3343","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"6946_CR37","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"New MI, Abraham M, Gonzalez B, Dumic M et al (2013) Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA 110(7):2611\u20136. https:\/\/doi.org\/10.1073\/pnas.1300057110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt A","key":"6946_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jsbmb.2015.10.011","volume":"155","author":"HH Nguyen","year":"2016","unstructured":"Nguyen HH, Eiden-Plach A, Hannemann F, Malunowicz EM et al (2016) Phenotypic, metabolic, and molecular genetic characterization of six patients with congenital adrenal hyperplasia caused by novel mutations in the CYP11B1 gene. J Steroid Biochem Mol Biol 155(Pt A):126\u2013134. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.10.011","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"6946_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000488034","volume":"89","author":"ES Baranowski","year":"2018","unstructured":"Baranowski ES, Arlt W, Idkowiak J (2018) Monogenic Disorders of Adrenal Steroidogenesis. Horm Res Paediatr 89(5):292\u2013310. https:\/\/doi.org\/10.1159\/000488034","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"6946_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1373\/clinchem.2003.027193","volume":"50","author":"JM Lacey","year":"2004","unstructured":"Lacey JM, Minutti CZ, Magera MJ, Tauscher AL et al (2004) Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem 50(3):621\u2013625. https:\/\/doi.org\/10.1373\/clinchem.2003.027193","journal-title":"Clin Chem"},{"issue":"7","key":"6946_CR41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1515\/jpem.2002.15.7.985","volume":"15","author":"N Weintrob","year":"2002","unstructured":"Weintrob N, Israel S, Lazar L, Lilos P, Brautbar C, Phillip M, Pertzelan A (2002) Decreased cortisol secretion in nonclassical 21-hydroxylase deficiency before and during glucocorticoid therapy. J Pediatr Endocrinol Metab 15(7):985\u2013991. https:\/\/doi.org\/10.1515\/jpem.2002.15.7.985","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"6946_CR42","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1210\/jc.2016-1543","volume":"101","author":"L Wallensteen","year":"2016","unstructured":"Wallensteen L, Zimmermann M, Thomsen Sandberg M, Gezelius A et al (2016) Sex-Dimorphic effects of prenatal treatment with dexamethasone. J Clin Endocrinol Metab 101(10):3838\u20133846. https:\/\/doi.org\/10.1210\/jc.2016-1543","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6946_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","volume":"41","author":"H Falhammar","year":"2012","unstructured":"Falhammar H, Thor\u00e9n M (2012) Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine 41(3):355\u2013373. https:\/\/doi.org\/10.1007\/s12020-011-9591-x","journal-title":"Endocrine"},{"issue":"6","key":"6946_CR44","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s00404-022-06441-3","volume":"306","author":"MR Mallmann","year":"2022","unstructured":"Mallmann MR, Gembruch U (2022) Clinical spectrum of female genital malformations in prenatal diagnosis. Arch Gynecol Obstet 306(6):1847\u20131862. https:\/\/doi.org\/10.1007\/s00404-022-06441-3","journal-title":"Arch Gynecol Obstet"},{"issue":"7","key":"6946_CR45","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/humrep\/den118","volume":"23","author":"K Hagenfeldt","year":"2008","unstructured":"Hagenfeldt K, Janson PO, Holmdahl G, Falhammar H, Filipsson H, Fris\u00e9n L, Thor\u00e9n M, Nordenskj\u00f6ld A (2008) Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 23(7):1607\u20131613. https:\/\/doi.org\/10.1093\/humrep\/den118","journal-title":"Hum Reprod"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-06946-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-06946-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-06946-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T09:07:30Z","timestamp":1689325650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-06946-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,11]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["6946"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-06946-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2308370\/v1","asserted-by":"object"}]},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,11]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in this clinical trial were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The studies involving human participants were reviewed and approved by the Ethics Committee of the Third Affiliated Hospital of Guangzhou Medical University (approval number 2022103).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}